Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark Gergen Insider Profile
4 Followers
Mark Gergen, Executive VP, COO at Mirati Therapeutics, holds 5.75K shares in Mirati Therapeutics (Ticker: MRTX), holds ― shares in Halozyme (Ticker: HALO), holds ― shares in Poseida Therapeutics (Ticker: PSTX).
Mark Gergen has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mark Gergen holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Mark Gergen
Mark Gergen's Trading History
Mirati Therapeutics
Jan 19, 2016
Executive VP, COO
Uninformative Sell
259.20K
$1.34M
Halozyme
―
SVP, Chief Operating Officer
―
―
Poseida Therapeutics
―
President and CBO, Director
―
―
List of latest transactions for each holding click on a transaction to see Mark Gergen's performance on stock
You May Also Like
Mark Gergen insider profile FAQ
What is the percentage of profitable transactions made by Mark Gergen?
The percentage of profitable transactions made by Mark Gergen is ―.
What is the average return per transaction made by Mark Gergen?
The average return per transaction made by Mark Gergen is ―.
What stocks does Mark Gergen hold?
Mark Gergen holds: MRTX, HALO, PSTX stocks.
What was Mark Gergen’s latest transaction?
Mark Gergen latest transaction was an Uninformative Sell of $259.20K.
What was Mark Gergen's most profitable transaction?
Mark Gergen’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Mark Gergen's role in Mirati Therapeutics?
Mark Gergen's role in Mirati Therapeutics is Executive VP, COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.